<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Percutaneous Radiofrequency Catheter Ablation </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with an <z:hpo ids='HP_0001631'>atrial septal defect</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>) commonly have <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) and closure of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> rarely controls the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report on the management of 4 patients with recurrent medically refractory AF in the setting of an unrepaired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> who underwent percutaneous RFA prior to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> closure </plain></SENT>
<SENT sid="3" pm="."><plain>In 3 of the 4 patients AF was controlled after ablation without antiarrhythmic drug therapy and in the fourth patient AF was controlled with antiarrhythmic therapy after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> closure </plain></SENT>
<SENT sid="4" pm="."><plain>Based on these limited results it seems reasonable to consider RFA of medically refractory AF in patients prior to planned percutaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> closure </plain></SENT>
</text></document>